Subversive Real Estate Acquisition REIT LP is a cannabis-focused SPAC with $225 million in trust and 1/8 share purchase rights (“SPR”) with no warrants. Michael Auerbach, Founder of Subversive Capital and former Tilray board member, serves as Chairman of SVX.
InterCure is the first public company on the Tel Aviv Stock Exchange to hold a valid and permanent license for the medical cannabis value chain through its 100% ownership in Canndoc. Canndoc is a GMP medical cannabis producer. Licensed by the Israeli Ministry of Health since 2008, Canndoc is a leading pioneer in the research, cultivation, production, and distribution of pharma-grade cannabis-based products to patients, hospitals, pharmacies, research and governmental organizations. Through its strategic exclusive collaboration with world leaders, distribution agreement with SLE (100% owned by Teva Pharmaceutical Industry) and long-term sales agreements, Canndoc is well-positioned as a leading and significant player in pharma-grade medical cannabis in Israel, Europe and the United Kingdom. The combined company will be led by Chairman and Former Prime Minister of Israel Ehud Barak and Canndoc CEO Alex Rabinovitch.